FIA
HCAT icon

FNY Investment Advisers’s Health Catalyst HCAT Stock Holding History

FNY Investment Advisers’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,000
Closed -$45K – 1127
2025
Q3 		$45K Buy
+16,000
New +$54.8K 0.01% 521
2019
Q4 		– Sell
-200
Closed -$6K – 910
2019
Q3 		$6K Buy
+200
New +$7.87K ﹤0.01% 630

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FNY Investment Advisers's HCAT Position: Q4 2025 in Review

FNY Investment Advisers sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 16,000 shares — an estimated $45K sold.

FNY Investment Advisers first reported a position in HCAT in Q3 2019 and held it in 2 quarters. The position peaked at $45K in Q3 2025. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • FNY Investment Advisers reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 16,000 Health Catalyst shares in Q4 2025, an estimated $45K.
  • FNY Investment Advisers first reported a position in Health Catalyst in Q3 2019 and held it in 2 quarters.
  • FNY Investment Advisers's Health Catalyst position peaked at $45K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.